Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000155448 | SCV000205139 | benign | not specified | 2013-02-25 | criteria provided, single submitter | clinical testing | proposed classification - variant undergoing re-assessment, contact laboratory |
Ambry Genetics | RCV000243682 | SCV000320140 | likely benign | Cardiovascular phenotype | 2015-10-23 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000464598 | SCV000554423 | benign | Atrioventricular septal defect 4 | 2024-01-26 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001582629 | SCV001813938 | likely benign | not provided | 2021-10-28 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 17352393) |
ARUP Laboratories, |
RCV001582629 | SCV003799493 | benign | not provided | 2022-03-31 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001582629 | SCV005220539 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV004019861 | SCV004742797 | likely benign | GATA4-related disorder | 2019-04-25 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |